Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perry Maxwell

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
BJU International|November 22, 2008
Changes in chromatin phenotype predict the response to hormonal deprivation therapy in patients with prostate cancerMahmoud Mohamed, Philipp A Greif, James Diamond, et al.
BJU International|March 24, 2007
Epigenetic events, remodelling enzymes and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinomaMahmoud A Mohamed, Philipp A Greif, James Diamond, et al.
Stem Cells (Dayton, Ohio)|November 18, 2006
Erythropoietin receptor expression in non-small cell lung carcinoma: a question of antibody specificityW Mark Brown, Perry Maxwell, Alastair N J Graham, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 11, 2012
BRCA1 immunohistochemical staining as a prognostic indicator in uterine serous carcinomaJames P Beirne, Jennifer E Quinn, Perry Maxwell, et al.
Cancers|August 7, 2021
A Means of Assessing Deep Learning-Based Detection of ICOS Protein Expression in Colon CancerMd Mostafa Kamal Sarker, Yasmine Makhlouf, Stephanie G Craig, et al.
Scientific Reports|March 22, 2016
Quantification of HER2 heterogeneity in breast cancer-implications for identification of sub-dominant clones for personalised treatmentNiamh E Buckley, Claire Forde, Darragh G McArt, et al.
Plos One|August 8, 2013
Validation of next generation sequencing technologies in comparison to current diagnostic gold standards for BRAF, EGFR and KRAS mutational analysisClare M McCourt, Darragh G McArt, Ken Mills, et al.
Oral Oncology|December 25, 2003
Identification and overexpression of human neutrophil alpha-defensins (human neutrophil peptides 1, 2 and 3) in squamous cell carcinomas of the human tongueFionnuala T Lundy, David F Orr, James R Gallagher, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 9, 2018
Critical Appraisal of Programmed Death Ligand 1 Reflex Diagnostic Testing: Current Standards and Future OpportunitiesMatthew P Humphries, Stephen McQuaid, Stephanie G Craig, et al.
The Journal of Pathology. Clinical Research|October 2, 2019
Systematic evaluation of PAXgene® tissue fixation for the histopathological and molecular study of lung cancerMark Southwood, Tomasz Krenz, Natasha Cant, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
BJU International|November 22, 2008
Changes in chromatin phenotype predict the response to hormonal deprivation therapy in patients with prostate cancerMahmoud Mohamed, Philipp A Greif, James Diamond, et al.
BJU International|March 24, 2007
Epigenetic events, remodelling enzymes and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinomaMahmoud A Mohamed, Philipp A Greif, James Diamond, et al.
Stem Cells (Dayton, Ohio)|November 18, 2006
Erythropoietin receptor expression in non-small cell lung carcinoma: a question of antibody specificityW Mark Brown, Perry Maxwell, Alastair N J Graham, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 11, 2012
BRCA1 immunohistochemical staining as a prognostic indicator in uterine serous carcinomaJames P Beirne, Jennifer E Quinn, Perry Maxwell, et al.
Cancers|August 7, 2021
A Means of Assessing Deep Learning-Based Detection of ICOS Protein Expression in Colon CancerMd Mostafa Kamal Sarker, Yasmine Makhlouf, Stephanie G Craig, et al.
Scientific Reports|March 22, 2016
Quantification of HER2 heterogeneity in breast cancer-implications for identification of sub-dominant clones for personalised treatmentNiamh E Buckley, Claire Forde, Darragh G McArt, et al.
Plos One|August 8, 2013
Validation of next generation sequencing technologies in comparison to current diagnostic gold standards for BRAF, EGFR and KRAS mutational analysisClare M McCourt, Darragh G McArt, Ken Mills, et al.
Oral Oncology|December 25, 2003
Identification and overexpression of human neutrophil alpha-defensins (human neutrophil peptides 1, 2 and 3) in squamous cell carcinomas of the human tongueFionnuala T Lundy, David F Orr, James R Gallagher, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 9, 2018
Critical Appraisal of Programmed Death Ligand 1 Reflex Diagnostic Testing: Current Standards and Future OpportunitiesMatthew P Humphries, Stephen McQuaid, Stephanie G Craig, et al.
The Journal of Pathology. Clinical Research|October 2, 2019
Systematic evaluation of PAXgene® tissue fixation for the histopathological and molecular study of lung cancerMark Southwood, Tomasz Krenz, Natasha Cant, et al.
Pageof 5